In the study of Rhee et al. [14] from Korea, protective effects against severe/lethal cases were shown in patients with T2DM who used DPP-4i in monotherapy or in combination with renin-angiotensin system blockers after adjusting for age, gender, comorbidity, and medications [14]. This evidence concerns the gene REN and type 2 diabetes mellitus.